In: BMC Medical Research Methodology, 19 (2019), Nr. 150. pp. 1-11. ISSN 1471-2288
![]() |
PDF, English
- main document
Download (1MB) | Lizenz: ![]() |
Abstract
Background: Randomized controlled trials are the gold-standard for clinical trials. However, randomization is not always feasible. In this article we propose a prospective and adaptive matched case-control trial design assuming that a control group already exists.
Methods: We propose and discuss an interim analysis step to estimate the matching rate using a resampling step followed by a sample size recalculation. The sample size recalculation is based on the observed mean resampling matching rate. We applied our approach in a simulation study and to a real data set to evaluate the characteristics of the proposed design and to compare the results to a naive approach.
Results: The proposed design achieves at least 10% higher matching rate than the naive approach at final analysis, thus providing a better estimation of the true matching rate. A good choice for the interim analysis seems to be a fraction of around 1/2 to 2/3 of the control patients.
Conclusion: The proposed resampling step in a prospective matched case-control trial design leads to an improved estimate of the final matching rate and, thus, to a gain in power of the approach due to sensible sample size recalculation.
Document type: | Article |
---|---|
Journal or Publication Title: | BMC Medical Research Methodology |
Volume: | 19 |
Number: | 150 |
Publisher: | BioMed Central ; Springer |
Place of Publication: | London ; Berlin, Heidelberg |
Date Deposited: | 15 Aug 2019 08:24 |
Date: | 2019 |
ISSN: | 1471-2288 |
Page Range: | pp. 1-11 |
Faculties / Institutes: | Medizinische Fakultät Heidelberg > Neurologische Universitätsklinik Medizinische Fakultät Heidelberg > Institut für Medizinische Biometrie |
DDC-classification: | 610 Medical sciences Medicine |
Uncontrolled Keywords: | Adaptive design, Clinical Trials, Sample size recalculation, Matched cohort, Prospective matching |